Hypermarcas (OTCMKTS:HYPMY – Get Free Report)’s stock price gapped down prior to trading on Friday . The stock had previously closed at $5.04, but opened at $4.75. Hypermarcas shares last traded at $4.6660, with a volume of 688 shares changing hands.
Hypermarcas Stock Performance
The company has a debt-to-equity ratio of 0.61, a current ratio of 1.27 and a quick ratio of 0.84. The stock has a market capitalization of $3.04 billion, a PE ratio of 20.87 and a beta of 0.72. The firm has a fifty day moving average price of $4.51 and a two-hundred day moving average price of $4.44.
Hypermarcas (OTCMKTS:HYPMY – Get Free Report) last issued its earnings results on Wednesday, November 12th. The company reported $0.13 earnings per share (EPS) for the quarter. Hypermarcas had a net margin of 12.03% and a return on equity of 6.89%. The company had revenue of $408.83 million for the quarter.
About Hypermarcas
Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.
Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.
Featured Stories
- Five stocks we like better than Hypermarcas
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- Refund From 1933: Trump’s Reset May Create Instant Wealth
- The $100 Trillion AI Story No One Is Telling You
Receive News & Ratings for Hypermarcas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hypermarcas and related companies with MarketBeat.com's FREE daily email newsletter.
